Join Now

Category Archives: BioUtah News

Co-Diagnostics, Inc. Completes Principal Design of Test for Monkeypox Virus

By Natalie Themm | Published May 31, 2022

Co-Diagnostics announced that it has completed the principal design work of a PCR test for the monkeypox virus currently exhibiting a multi-country outbreak.

| Tagged , | Leave a comment

Biomerics Announces Image Guided Intervention Division

By admin | Published May 26, 2022

SALT LAKE CITY, UTAH (Monday, May 2, 2022) – Biomerics, a leading vertically integrated contract manufacturer for the attractive interventional device market, announced the creation of a new division, Biomerics Image Guided Intervention (IGI). Biomerics’ IGI Division, headquartered in Salt Lake City, provides advanced image generation and processing technologies to enable real-time minimally invasive advanced […]

| Leave a comment

bioMérieux receives De Novo FDA Authorization for its BIOFIRE® Joint Infection (JI) Panel

By Natalie Themm | Published May 25, 2022

Marcy l’Étoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, today announces that its BIOFIRE® Joint Infection (JI) Panel has received De Novo authorization from the US Food and Drug Administration (FDA). This panel tests for 31 pathogens implicated in most acute joint infections, and also includes 8 antimicrobial resistance (AMR) […]

| Tagged | Leave a comment

PolarityTE to Effectuate 1-for-25 Reverse Stock Split

By Natalie Themm | Published May 18, 2022

PolarityTE announced that the Company will effectuate a 1-for-25 reverse stock split of the Company’s issued and outstanding common stock.

| Tagged | Leave a comment

PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update

By Natalie Themm | Published May 16, 2022

PolarityTE provided a business update and reported financial results for the three-month period ended March 31, 2022.

| Tagged | Leave a comment

PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®

By Natalie Themm | Published May 16, 2022

PolarityTE announced that the U.S. FDA granted a Regenerative Medicine Advanced Therapy (RMAT) designation to SkinTE under the Company’s open IND. 

| Tagged | Leave a comment

BioHive Takes the Stage at One Utah Summit

By Denise Bell | Published May 12, 2022

The BioHive community was featured prominently at the One Utah Summit held on May 10 at the Grand America Hotel in Salt Lake City. Speakers from the life sciences industry addressed the crowd on topics ranging from job creation and talent development to life-saving innovation and drug discovery. Tom Polen, CEO of BD, and Rob […]

Also posted in Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Recursion Co-Founder and CEO, Chris Gibson, Awarded Governor’s Medal for Science and Technology

By Denise Bell | Published May 12, 2022

Recursion Co-founder and CEO, Chris Gibson, Ph.D., was honored at the One Utah Summit on May 10, receiving the Governor’s Medal for Science and Technology. Gov. Spencer Cox presented the award during the summit’s special recognition ceremony. The prestigious award commends the distinguished service, significant achievement, and positive economic impact of individuals to the state […]

Also posted in Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Recursion CEO, Chris Gibson, Awarded Governor’s Medal for Science and Technology

By admin | Published May 12, 2022

Recursion CEO, Chris Gibson, Ph.D., was honored at the One Utah Summit on May 10, receiving the Governor’s Medal for Science and Technology. Gov. Spencer Cox presented the award which recognizes the distinguished service, significant achievement, and positive economic impact of individuals to the state of Utah and beyond in the fields of science and […]

| Leave a comment

IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’

By Natalie Themm | Published May 11, 2022

IONIQ Receives Three Awards including ‘Best Medical Technology Company 2022’

| Tagged | Leave a comment

BlueWind Medical Raises $64 Million to Fund Innovative Technology for Overactive Bladder (OAB) Treatment

By Natalie Themm | Published May 11, 2022

RENOVA iStim™ implantable tibial neuromodulation device is being studied as a minimally invasive, patient-centric solution for the treatment of OAB.

| Tagged | Leave a comment

New Executive Appointments Position ARUP Laboratories for Future Growth

By Natalie Themm | Published May 11, 2022

New Executive Appointments Position ARUP Laboratories for Future Growth

| Tagged | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members